研究111 - 104 招聘
A第一期, 随机, 非盲, Sponsor-Open, Two-Sequence, Two-Period Crossover Study to Investigate the Bioequivalence of a Single Subcutaneous Dose of BMN 111 Administered Using Either a Vial and Syringe or Injector Pen in Healthy Adult Participants
指示
软骨发育不全
目标
Investigate the Bioequivalence of a Single Subcutaneous Dose of BMN 111 Administered Using Either a Vial and Syringe or Injector Pen in Healthy Adult Participants
临床实验的治疗
Combination Product: BMN111 administration via Injector Pen, 药物:BMN111通过小瓶和注射器给药
状态
这项研究目前正在招募参与者
研究类型
第一阶段